Dissecting the World's Biggest Diabetes Drug Stock

The Motley Fool's health care show "Market Checkup" focuses this week on diabetes, one of America's growing health care concerns. There are 2 versions of this chonic disease -- the more prevalent being type 2 diabetes, which makes up about 95% of all cases. Because of that overwhelming patient population, type 2 diabetes receives the majority of attention from big pharma companies.

Diabetes is no small problem. In 2010, one in ten adults has diabetes, and more troubling, more than one in four senior citizens, making it the seventh leading cause of death. There are 2 million new cases in America per year, leading analysts to project spending on diabetes to approach $60 billion in just 5 years. And this isn't just an American problem; 370 million suffer from diabetes around the world.

In this video health care analysts David Williamson and Max Macaluso discusses a big pharma stock that is essentially a diabetes pure play in Novo Nordisk (NYSE: NVO  ) . Watch and discover what potential game-changing treatment options Novo has in its pipeline as it tries to maintain a dominant position in diabetes treatment.

Rising health care costs continue to be a hotly debated topic, and even legendary investor Warren Buffett called this trend "the tapeworm that's eating at American competitiveness." To learn more about what's happening to the health care system -- and how to potentially profit from this trend -- click here for free, immediate access.

Follow David on Twitter: @MotleyDavid.


Read/Post Comments (3) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On July 05, 2013, at 4:42 PM, marp11 wrote:

    diabetes drugs?? first line diabetes treatment.

    try BEL/PHNE

    BELVIQ FORM ARNA COMBINED WITH PHENAMINE

    DO YOUR DD

    IT WORKS ,,IT WILL BLOW THE DRUG INDUSTRY AWAY

    WHY DO U THONK THEY ARE TRYING SO HARD TO KEEP ARNA PRICE DOWN??

    SHORT POSITION IS DESTROYED IN A FEW MONTHS OR WEEKS

    HAVE A GREAT DAY

  • Report this Comment On July 05, 2013, at 5:01 PM, marp11 wrote:

    THAT BEL /PHEN

    REMEMBER IT

    arna stock is like owning apple at $1

  • Report this Comment On July 05, 2013, at 5:19 PM, Andy205 wrote:

    I too own ARNA, but I pay lot of attention what people are talking. BEL/PHEN may be a good combination drug and results may be positive, but doctors and market analysts may need to participate and stop this mud throwing attitude. Today or tomorrow truth will come out.

Add your comment.

DocumentId: 2524625, ~/Articles/ArticleHandler.aspx, 7/26/2014 3:53:14 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement